From: Taking stock: provider prescribing practices in the presence and absence of ACT stock
Country, Year | % (No.) of patients diagnosed with uncomplicated malaria/fever and prescribed Alternative (non-ACT) Anti-Malarial | |||
---|---|---|---|---|
At all facilities, % (n) | At facilities with ACT stock, % (n) | At facilities with no ACT stock, % (n) | % differencea (95% Confidence Intervalc; p-value) | |
Kenya, 2006 [19] | 50.5% (475/940) | 47.8% (414/866) | 82.4% (61/74) | -34.6% (-44.6%, -24.6%; p < 0.001) |
Kenya, 2010 [14] | 8.6% (183/2125) | 8% (162/2025) | 21% (21/100) | -13% (-21.6%, -4.4%; p < 0.001) |
Uganda, 2007 [18] | < 5 yrs | < 5 yrs | < 5 yrs | < 5 yrs |
19.5% (90/461) | 16.4% (70/428) | 60.6% (20/33) | -44.2% (-62.9%, -25.6%; p < 0.001) | |
≥ 5 yrs | ≥ 5 yrs | ≥ 5 yrs | ≥ 5 yrs | |
26.7% (197/739) | 22.5% (145/644) | 54.7% (52/95) | -32.2% (-43.3%, -21.1%; p < 0.001) | |
Zambia, 2004 [16] | ≥ 10 kg | ≥ 10 kg | ≥ 10 kg | ≥ 10 kg |
72.3% (285/394) | 56.8% (109/192) | 87.1% (176/202) | -30.3% (-39.3%, -21.5%, p < 0.001) | |
Zambia, 2006 [17] | 5-9 kg | 5-9 kg | 5-9 kg | 5-9 kg |
43.5% (240/552) | 24.2% (85/351) | 77.1% (155/201) | -52.9% (-60.6%, -45.2%; p < 0.001) | |
≥ 10 kg | ≥ 10 kg | ≥ 10 kg | ≥ 10 kg | |
34.6% (189/547) | 17.4% (65/374) | 71.7% (124/173) | -54.3% (-62.5%, -46.1%; p < 0.001) | |
Zambia, 2006 [15]b | 36.6% (533/1457) | 23.1% (240/1040) | 70.3% (293/417) | -47.2% (-52.4%, -41.9%; p < 0.001) |